BHVN Biohaven Ltd.
Healthcare$9.45-0.32%ClosedMarket Cap: $1.00B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$16.50
Target (Median)
$16.50
Target Range
$10.00 - $23.00
Upside from current price: 74.6%
Rating Distribution
4 Strong Buy10 Buy5 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-05-05 | RBC Capital | maintain | Outperform | Outperform |
| 2026-04-02 | Citigroup | maintain | Buy | Buy |
| 2026-03-11 | TD Cowen | maintain | Buy | Buy |
| 2026-03-04 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| 2026-03-03 | RBC Capital | maintain | Outperform | Outperform |
| 2026-01-21 | RBC Capital | upgrade | Outperform | Sector Perform |
| 2026-01-06 | Morgan Stanley | maintain | Overweight | Overweight |
| 2025-12-26 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| 2025-11-26 | UBS | downgrade | Neutral | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.44 | $16.9M | 11 |
| Sun Dec 31 | $-2.14 | $89.2M | 15 |
| Mon Dec 31 | $-1.53 | $277.9M | 10 |
| Tue Dec 31 | $0.21 | $719.5M | 6 |